Alzheimer's Disease Selectively Perturbs Age-Sensitive Brain Radiomic Features Across the Disease Continuum
Megha Suman SharmaiD, Rajat AgarwaliD, Nikita TiwariiD, Ajay Kaushik, the Frontotemporal Lobar Degeneration Neuroimaging Initiative
Abstract
Normal brain aging and Alzheimers disease both involve progressive structural brain alterations, making it challenging to distinguish pathological neurodegeneration from normative aging-related atrophy. This study investigated whether Alzheimers disease exhibits radiomic patterns that mimic, diverge from, or selectively perturb age-associated structural brain changes. T1-weighted magnetic resonance imaging scans from the Alzheimers Disease Neuroimaging Initiative were analyzed using a region-wise radiomics framework across 10 anatomically defined brain regions. Radiomic features were extracted following automated segmentation, bias field correction, and intensity normalization. Age-associated radiomic patterns were first identified in cognitively normal subjects using Spearman correlation analysis. Features demonstrating significant age sensitivity were subsequently compared between cognitively normal and Alzheimers disease cohorts across age bins using Welchs two-sample t-tests with permutation-based significance estimation and false discovery rate correction. Medial temporal and limbic regions, particularly the hippocampus, entorhinal cortex, and cingulum, demonstrated consistent age-aligned radiomic trajectories with systematic, statistically significant disease-related shifts across all age bins, supported by large effect sizes and bootstrap-validated confidence intervals. In contrast, several other regions demonstrated more heterogeneous and less stable patterns of group separation across age bins. Secondary analysis using late mild cognitive impairment subjects demonstrated that these radiomic divergences are detectable at the transition from normal cognition to mild cognitive impairment, with statistically significant CN-LMCI separation but no significant LMCI-AD separation, positioning the identified markers as early-stage rather than late-stage indicators of neurodegeneration. These findings indicate that Alzheimers disease does not uniformly mimic normal aging across the brain but instead selectively perturbs radiomic features associated with normative aging trajectories. The identified markers represent promising candidates for age-adjusted radiomic biomarkers, warranting validation in independent cohorts to establish their generalisability. The fully automated nature of the analytical pipeline -- spanning segmentation, feature extraction, and statistical comparison without manual annotation -- may facilitate scalable validation of these biomarkers in larger neuroimaging cohorts.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alzheimers Disease Brain Phenotypes are Age-dependent
Fermín Travi, Anushree Mehta, … Pablo I. Polosecki·bioRxiv·Apr 16, 2026
- Preserved cognition in elderly with intact rhinal cortex
Farshid Sepehrband, Kirsten M. Lynch, … the Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·May 30, 2022
- Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease
Monireh Taimouri, Vikram Ravindra·bioRxiv·Jun 24, 2026
- Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration
Alexei Taylor, Fengqing Zhang, … the Alzheimer’s Disease Neuroimaging Initiative·NeuroImagePeer-reviewed·Sep 9, 2022
- Enhancing Brain Age Prediction and Neurodegeneration Detection with Contrastive Learning on Regional Biomechanical Properties
Jakob Träuble, Lucy V. Hiscox, … Gabriele S. Kaminski Schierle·bioRxiv·Mar 25, 2025
- Subregional Biomarkers in FDG PET for Alzheimer's Diagnosis and Staging: An Interpretable and Explainable model
Ramin Rasi, Albert Güveniş, the Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·Dec 27, 2024